Valère @valere@hostux.social

Highlights

• This was the first randomized, double-blinded, placebo-controlled clinical trial evaluating outpatients with mild COVID-19

• Viral clearance rates within a 9-day period from symptom onset did not change with hydroxychloroquine and azithromycin (HCQ/AZT) treatment

• The use of HCQ/AZT combination was safe and not associated with more adverse effects or major cardiovascular events

Une étude randomisée en double aveugle contre placebo sur l’efficacité de l’association hydroxychloroquine/azithromycine sur la diminution de la charge virale.

https://www.sciencedirect.com/science/article/pii/S0924857921002065

Hardening Firefox - September 2021 Update
https://brainfucksec.github.io/hardening-firefox-sep-2021-update

Matin o/

POUET